» Articles » PMID: 8202532

Granulocyte/macrophage Colony-stimulating Factor-deficient Mice Show No Major Perturbation of Hematopoiesis but Develop a Characteristic Pulmonary Pathology

Overview
Specialty Science
Date 1994 Jun 7
PMID 8202532
Citations 269
Authors
Affiliations
Soon will be listed here.
Abstract

Mice homozygous for a disrupted granulocyte/macrophage colony-stimulating factor (GM-CSF) gene develop normally and show no major perturbation of hematopoiesis up to 12 weeks of age. While most GM-CSF-deficient mice are superficially healthy and fertile, all develop abnormal lungs. There is extensive peribronchovascular infiltration with lymphocytes, predominantly B cells. Alveoli contain granular eosinophilic material and lamellar bodies, indicative of surfactant accumulation. There are numerous large intraalveolar phagocytic macrophages. Some mice have subclinical lung infections involving bacterial or fungal organisms, occasionally with focal areas of acute purulent inflammation or lobar pneumonia. Some features of this pathology resemble the human disorder alveolar proteinosis. These observations indicate that GM-CSF is not essential for the maintenance of normal levels of the major types of mature hematopoietic cells and their precursors in blood, marrow, and spleen. However, they implicate GM-CSF as essential for normal pulmonary physiology and resistance to local infection.

Citing Articles

Identification of TNFAIP2 as a unique cellular regulator of CSF-1 receptor activation.

Abdelnaser R, Hiyoshi M, Takahashi N, Eltalkhawy Y, Mizuno H, Kimura S Life Sci Alliance. 2025; 8(5).

PMID: 39939179 PMC: 11821806. DOI: 10.26508/lsa.202403032.


Alveolar Macrophages in Viral Respiratory Infections: Sentinels and Saboteurs of Lung Defense.

Popperl P, Stoff M, Beineke A Int J Mol Sci. 2025; 26(1.

PMID: 39796262 PMC: 11721917. DOI: 10.3390/ijms26010407.


Induced pluripotent stem cell-derived macrophages as a platform for modelling human disease.

Tiwari S, Wong W, Moreira M, Pasqualini C, Ginhoux F Nat Rev Immunol. 2024; 25(2):108-124.

PMID: 39333753 DOI: 10.1038/s41577-024-01081-x.


Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis.

Lettieri S, Bonella F, Marando V, Franciosi A, Corsico A, Campo I Eur Respir Rev. 2024; 33(173).

PMID: 39142709 PMC: 11322829. DOI: 10.1183/16000617.0064-2024.


Cancer immunotherapies: A hope for the uncurable?.

Hamdan F, Cerullo V Front Mol Med. 2024; 3:1140977.

PMID: 39086690 PMC: 11285639. DOI: 10.3389/fmmed.2023.1140977.


References
1.
Morse 3rd H, Davidson W, Yetter R, Coffman R . A cell-surface antigen shared by B cells and Ly2+ peripheral T cells. Cell Immunol. 1982; 70(2):311-20. DOI: 10.1016/0008-8749(82)90332-x. View

2.
Rosen S, Castleman B, LIEBOW A . Pulmonary alveolar proteinosis. N Engl J Med. 1958; 258(23):1123-42. DOI: 10.1056/NEJM195806052582301. View

3.
Yelton D, Desaymard C, Scharff M . Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies. Hybridoma. 1981; 1(1):5-11. DOI: 10.1089/hyb.1.1981.1.5. View

4.
Miyatake S, Otsuka T, Yokota T, Lee F, Arai K . Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes. EMBO J. 1985; 4(10):2561-8. PMC: 554544. DOI: 10.1002/j.1460-2075.1985.tb03971.x. View

5.
Stanley E, Metcalf D, Sobieszczuk P, Gough N, Dunn A . The structure and expression of the murine gene encoding granulocyte-macrophage colony stimulating factor: evidence for utilisation of alternative promoters. EMBO J. 1985; 4(10):2569-73. PMC: 554545. DOI: 10.1002/j.1460-2075.1985.tb03972.x. View